Home

Department of Hematology

The Hematology Department at Gustave Roussy treats blood and bone marrow cancers in adults. Its specialized teams support patients at every stage of their care journey, from diagnosis to the most innovative treatments, drawing on recognized expertise, cutting-edge research, and a multidisciplinary approach.

The department’s physicians work closely with clinical laboratory teams specializing in hematology, as well as with other departments at Gustave Roussy.

This organizational structure enables the department to offer each patient personalized care, based on the most recent international guidelines and access to therapeutic innovations.

Department
Chair: Prof. Stéphane de Botton

 

Key Figures

  • 4

    inpatient units

  • 1

    13-bed outpatient clinic

  • 46

    hospital beds

  • 1

    outpatient department

Conditions Treated

Myeloid Hematologic Disorders

  • Acute and Chronic Myeloid Leukemias
  • Myeloproliferative syndromes
  • Myeloproliferative syndromes
  • Mixed myelodysplastic and myeloproliferative disorders

Lymphoid blood disorders

  • Acute and chronic lymphoid leukemias
  • Non-Hodgkin lymphomas
  • Hodgkin's disease
  • Multiple myeloma

What is a malignant blood disorder?

Malignant hematologic diseases are cancers that affect the cells of the blood, bone marrow, or lymphatic system. They include, in particular, leukemias, lymphomas, and myelomas.

Department Organization

Outpatient Hospital

  • 13 beds
  • Ground floor of the Institute

Secured Intensive Care Units

Paris D4

  • 11 beds
  • 8th floor

Paris D3

  • 11 beds
  • 8th floor

Suzanne Axel 

  • 12 beds
  • 8th floor

Manche

  • 12 beds
  • 8th floor

Research and Innovation

Innovative Treatments Available to Our Patients

The goal of the department’s research program is to offer each patient the best available treatment options, including innovative treatments currently under evaluation when they are appropriate for the patient’s situation.

The studies offered comply with a strict regulatory framework and always require the patient’s consent.

Participate in the research

Phase III clinical trials

A comparison of a standard-of-care treatment with a new therapeutic strategy that has shown promising preliminary results.

Phase I and II clinical trials

Proposal of innovative treatments when standard treatments have not yielded the expected results, in collaboration with DITEP.

Non-therapeutic studies

Additional blood or bone marrow samples collected to advance scientific understanding of hematologic diseases.

Patient Rights

All research is approved by the relevant authorities and an ethics committee. Participation is voluntary and may be discontinued at any time.

Our Major Areas of Research

Education and Training

The department's physicians participate in the training of medical students at Paris-Saclay University and regularly host interns and students in training.

The teams are also involved in postgraduate education and in training programs for French and international healthcare professionals.

Department officials

Contacts

Hematology Clinic

Phone reception for new patients and medical emergencies only (9 a.m.–5 p.m.):
Tel.: +33 (0)1 42 11 67 15
Fax: +33 (0)1 42 11 52 70

Transplant - Pre-transplant evaluation coordination: 
+33 (0)1 42 11 42 39